Cancers, Vol. 11, Pages 1819: Reactivation of Hepatitis B Virus in Patients with Multiple Myeloma
In this study, around 20% of all patients with HBV reactivation developed HBV reactivation after 2 years from the initiation of therapy, unlike malignant lymphoma. This might be due to the fact that almost all of the patients received chemotherapy for a long duration. Therefore, a new strategy for the prevention of HBV reactivation in MM patients is required.
Source: Cancers - Category: Cancer & Oncology Authors: Yutaka Tsukune Makoto Sasaki Norio Komatsu Tags: Review Source Type: research
More News: Antiviral Therapy | Cancer | Cancer & Oncology | Chemotherapy | Hematology | Hepatitis | Hepatitis B | Japan Health | Lymphoma | Myeloma | Stem Cell Therapy | Stem Cells | Study | Transplants